AIZ vs EDIT · P/E 15, rev $12.81B vs rev $32.3M
Assurant Inc (AIZ) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Assurant Inc (AIZ) is a insurance - property & casualty company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported AIZ revenue for 2025-12-31 was $12.81B. Net income was $872.7M. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. AIZ currently screens at market cap $9.98B and trailing P/E 15.4.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
AIZ currently screens at market cap $9.98B and trailing P/E 15.4. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the AIZ and EDIT stock pages for the full models.
Not investment advice.